Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than does fatty liver or nonalcoholic fatty liver disease.

Marenao TanakaKazuma MoriSatoko TakahashiYukimura HigashiuraHirofumi OhnishiNagisa HanawaMasato Furuhashi

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)

MAFLD is modestly and independently associated with new onset of CKD and predicts the risk for development of CKD better than does FL or NAFLD.

Keyphrases

chronic kidney disease
end stage renal disease
fatty acid
oxidative stress